School of Medicine, Universidad Durango-Santander, Hermosillo 83165, Mexico.
CONACyT-Centro de Investigacion Biomedica de Occidente, Instituto Mexicano del Seguro Social, Sierra Mojada #800 Col. Independencia, Guadalajara 44340, Jalisco, Mexico.
Medicina (Kaunas). 2019 Aug 23;55(9):522. doi: 10.3390/medicina55090522.
Kidneys have an important role in regulating water volume, blood pressure, secretion of hormones and acid-base and electrolyte balance. Kidney dysfunction derived from acute injury can, under certain conditions, progress to chronic kidney disease. In the late stages of kidney disease, treatment is limited to replacement therapy: Dialysis and transplantation. After renal transplant, grafts suffer from activation of immune cells and generation of oxidant molecules. Anesthetic preconditioning has emerged as a promising strategy to ameliorate ischemia reperfusion injury. This review compiles some significant aspects of renal physiology and discusses current understanding of the effects of anesthetic preconditioning upon renal function and ischemia reperfusion injury, focusing on opioids and its properties ameliorating renal injury. According to the available evidence, opioid preconditioning appears to reduce inflammation and reactive oxygen species generation after ischemia reperfusion. Therefore, opioid preconditioning represents a promising strategy to reduce renal ischemia reperfusion injury and, its application on current clinical practice could be beneficial in events such as acute renal injury and kidney transplantation.
肾脏在调节水容量、血压、激素分泌以及酸碱和电解质平衡方面发挥着重要作用。急性损伤引起的肾功能障碍在某些条件下可进展为慢性肾脏病。在肾脏病的晚期,治疗仅限于替代疗法:透析和移植。肾移植后,移植物会受到免疫细胞的激活和氧化剂分子的产生。麻醉预处理已成为改善缺血再灌注损伤的一种有前途的策略。本综述汇编了一些肾脏生理学的重要方面,并讨论了麻醉预处理对肾功能和缺血再灌注损伤的影响的最新认识,重点介绍了阿片类药物及其改善肾损伤的特性。根据现有证据,阿片类药物预处理似乎可以减少缺血再灌注后的炎症和活性氧的产生。因此,阿片类药物预处理代表了一种减少肾缺血再灌注损伤的有前途的策略,其在当前临床实践中的应用可能有益于急性肾损伤和肾移植等事件。